PROVIDER PROFILE · NPI 1164942330

Kara Gerbino

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

1,254

Beneficiaries

—

Total drug cost

$9.0M

Distinct drugs

Brand share

50.2%

Top prescribed drugs

Selexipag127 claims

Riociguat124 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$8K

Payment records

By payment type

Consulting Fee$4K

Food and Beverage$3K

Travel and Lodging$1K

Education$99

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

Hospital

CROSS-REFERENCE